HJ Science Co., Ltd. focuses on developing highly differentiated small-molecule innovative therapies in metabolic diseases, oncology, and autoimmune disorders. Our pipeline spans preclinical to different clinical stages. At JPM Week 2026, we are seeking out-licensing, NewCo collaboration, and equity investment partnership opportunities.
Address
ChengduChina
